SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Divis Laboratories board to consider financial results

24 Jul 2012 Evaluate
Divis Laboratories has informed that a meeting of the board of directors of the company will be held on August 04, 2012, to consider and approve, the un-audited financial results for the first quarter ended June 30, 2012.

The above information is a part of company's filings submitted to BSE.

Divis Laboratories Share Price

6751.05 7.90 (0.12%)
24-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1874.70
Dr. Reddys Labs. 1328.35
Cipla 1437.35
Zydus Lifesciences 1099.10
Lupin 2367.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: